Yelena Novik

Biosketch / Results /

Yelena Novik, M.D.

Associate Professor; Section Chief Hematology Onc BV Can Ctr
Department of Medicine (Residency Program)
NYU Medical Oncology Associates

Clinical Addresses

160 EAST 34TH STREET
NEW YORK, NY 10016
Hours: Mon. 9 - 5; Tue. 9 - 5; Wed. 9 - 6; Thu. 9 - 5; Fri. 9 - 5
Handicap Access: yes
Phone: 212-731-5350
Fax: 212-731-5574

« Back to Results

Medical Specialties

Cancer, Medical Oncology

Medical Expertise

Breast Oncology, Cancer Disparities, Hormonal Therapy for Breast Cancer, Melanoma, Cancer Clinical Trials, Breast Cancer, High Risk Breast Cancer

Clinical Responsibilities

Dr. Yelena Novik is Associate Professor of Medicine at the Perlmutter Cancer Center, NYU Langone Medical Center, NYU School of Medicine, and Chief of Medical Oncology and Hematology Service at the Bellevue Cancer Center, Deputy Director of the Bellevue Cancer Center.

Dr. Novik is Chair of one of four NYU School of Medicine Institutional Review Boards, she is also the Chair of the Bellevue Cancer Committee.

Dr. Novik's clinical expertise is to provide state-of-the-art care in the prevention, diagnosis, and treatment of breast cancer, including chemoprevention and management of high risk for cancer cases, hormonal therapy, biologic therapy, chemotherapy in an integrative approach. Dr. Novik is a renowned expert in breast cancer management and in addressing all the aspects of the complex medical needs of patients with this disease.

Dr. Novik has been selected on multiple occasions by her peers, consumer reports and patients as top in her profession: Selected to "New York Super Doctors"(2013-2014); Top Oncologist and Breast Cancer Specialist, (2012-2013) by Leading Physicians of the World; America's Top Oncologist (2007) by Consumer's Research Council of America and America's Top Physician (2004-2005) by Consumer's Research Council of America. She is a Fellow of the American College of Physicians.

Dr. Novik's research interests focus on the treatment of breast cancer, clinical trials and service in cancer care to underrepresented minorities. She has contributed numerous peer-reviewed manuscripts and book chapters to the current peer reviewed literature and lectures regularly to the trainees, colleagues and patients.

Languages

Russian

Insurance

AETNA HMO, AETNA INDEMNITY, AETNA MEDICARE, AETNA POS, AETNA PPO/EPO, AFFINITY, AFFINITY EXCHANGE- ESSENTIAL, CIGNA EPO/POS, Cigna PPO, EBCBS EPO, EBCBS HLTHY NY, EBCBS HMO, EBCBS INDEMNITY, EBCBS MEDIBLUE, EBCBS POS, EBCBS PPO, ELDERPLAN, GHI CBP, HEALTHREPUBLIC, HIP ACCESS I, HIP ACCESS II, HIP CHLD HLTH, HIP EPO/PPO, HIP FAM HLTH, HIP HMO, HIP MEDICARE, HIP POS, LOCAL 1199 PPO, MAGNACARE PPO, MULTIPLAN/PHCS PPO, Medicare, NYS EMPIRE PLAN, OSCAR, OXFORD EXCHANGE, OXFORD FREEDOM, Oxford Liberty, Oxford Medicare, Tricare, UHC COMMUNITY & STATE PLAN, UHC EPO, UHC HMO, UHC MEDICARE, UHC POS, UHC PPO, UHC TOP TIER, UNITED EXCHANGE- COMPASS

Insurance Disclaimer: Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have changed.

« Back to Results

Board Certification

2007 — Ab Internal Medicine (Medical Oncology)

Education

1984-1988 — Moscow State University of Medicine and Dentistry, Medical Education
1990-1993 — Montefiore Medical Center (Medicine (Internal)), Residency Training
1993-1996 — Montefiore Medical Center (Hematology & Oncolog), Clinical Fellowships

« Back to Results

All data from NYU Health Sciences Library Faculty Bibliography — -

Contact:
http://hsl.med.nyu.edu/faculty-bibliography-search

Clinical Trial Evidence of the Antitumor Activity of Topical Imiquimod for Breast Cancer Skin Metastases
Adams, Sylvia; Novik, Yelena; Oratz, Ruth; Axelrod, Deborah; Speyer, James; Tiersten, Amy; Goldberg, Judith D; Bhardwaj, Nina; Unutmaz, Derya; Demaria, Sandra; Formenti, Silvia
2014 Aug;:445-445, Journal of clinical oncology
— id: 1105352, year: 2014, vol: , page: 445, stat: Journal Article,

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
Singh, JC; Novik, Y; Stein, S; Volm, M; Meyers, M; Smith, J; Omene, C; Speyer, J; Schneider, R; Jhaveri, K; Formenti, S; Kyriakou, V; Joseph, B; Goldberg, JD; Li, X; Adams, S; Tiersten, A
2014 ;16(2):- R32, Breast cancer research
— id: 1059672, year: 2014, vol: 16, page: , stat: Journal Article,

Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery
Tam, Moses; Narayana, Ashwatha; Raza, Shahzad; Kunnakkat, Saroj; Golfinos, John G; Parker, Erik C; Novik, Yelena
2014 Feb;31(2):832-832, Medical oncology
— id: 761132, year: 2014, vol: 31, page: 832, stat: Journal Article,

Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases
Janosky, M D; Demaria, S; Novik, Y; Oratz, R; Tiersten, A; Goldberg, J D; Wang, E; Marincola, F; Formenti, S; Adams, S
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 451782, year: 2013, vol: 31, page: , stat: Journal Article,

RAD001-carboplatin combination in triple-negative metastatic breast cancer (TNMBC): A phase II trial
Singh, J C; Stein, S; Volm, M; Smith, J A; Adams, S; Meyers, M; Speyer, J L; Novik, Y; Schneider, R; Formenti, S; Muggia, F; Jhaveri, K L; Goldberg, J D; Heese, S; Li, X; Davis, S; Tiersten, A
2013 20 May 2013;31(15):-, Journal of clinical oncology
— id: 452012, year: 2013, vol: 31, page: , stat: Journal Article,

Novel Combination of Toll-Like Receptor (TLR)-7 Agonist Imiquimod and Local Radiation Therapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall
Vatner, R. ; Demaria, S. ; Fenton-Kerimian, M. ; Novik, Y. ; Oratz, R. ; Tiersten, A. ; Goldberg, J. D. ; Adams, S. ; Formenti, S.
2013 OCT 1;87(2 S S):S111-S111, International journal of radiation oncology biology physics
— id: 657332, year: 2013, vol: 87, page: S111, stat: Journal Article,

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
Adams, S; Kozhaya, L; Martiniuk, F; Meng, TC; Chiriboga, L; Liebes, L; Hochman, T; Shuman, N; Axelrod, D; Speyer, JL; Novik, Y; Tiersten, A; Goldberg, JD; Formenti, SC; Bhardwaj, N; Unutmaz, D; Demaria, S
2012 Jul;:6748-6757, Clinical cancer research
— id: 171476, year: 2012, vol: , page: 6748, stat: Journal Article,

Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer
Singh, J C; Stein, S; Volm, M; Smith, J A; Novik, Y; Speyer, J L; Meyers, M; Adams, S; Omene, C O; Muggia, F; Schneider, R; Formenti, S; Davis, S; Beardslee, B; Tiersten, A
2012 20 May 2012;30(15):-, Journal of clinical oncology
— id: 249952, year: 2012, vol: 30, page: , stat: Journal Article,

Efficacy of RAD001/carboplatin in triple-negative metastatic breast cancer: A phase II study
Singh, J C; Volm, M; Novik, Y; Speyer, J L; Adams, S; Omene, C O; Meyers, M I; Smith, J A; Schneider, R; Formenti, S; Goldberg, J D; Li, X; Davis, S; Beardslee, B; Tiersten, A
2012 20 Sep 2012;30(27):-, Journal of clinical oncology
— id: 395172, year: 2012, vol: 30, page: , stat: Journal Article,

Minimal Acute Toxicity Associated With Concurrent Adjuvant Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer
Vatner, R.; Fenton-Kerimian, M.; Novik, Y.; Volm, M.; Tiersten, A.; Oratz, R.; Speyer, J.; Formenti, S. C.
2012 NOV 1;84(3 S S):S251-S251, International journal of radiation oncology biology physics
— id: 204692, year: 2012, vol: 84, page: S251, stat: Journal Article,

Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer
Fasano, Julie; Hershman, Dawn; Novik, Yelena; Levinson, Benjamin; Blozie, Kim; Tiersten, Amy D
2010 Mar;5(1):17-21, Breast care
— id: 211592, year: 2010, vol: 5, page: 17, stat: Journal Article,

Outcomes of Stereotactic Radiosurgery in the Management of Brain Metastasis in Patients with HER2 Positive Metastatic Breast Cancer
Raza, S; Narayana, A; Morsi, A; Parker, E; Rush, S; Golfinos, J; Novik, Y
2009 DEC 15 ;69(24):874S-874S, Cancer research
— id: 106461, year: 2009, vol: 69, page: 874S, stat: Journal Article,

A phase 2 study of moderate dose interleukin-2 and granulocyte-macrophage colony-stimulating factor in patients with metastatic or unresectable renal cell carcinoma
Koulova, Lydia; Novik, Yelena; Caliendo, Geralyn; Wiernik, Peter; Dutcher, Janice
2005 Nov-Dec;28(6):576-581, Journal of immunotherapy (Hagerstown)
— id: 96877, year: 2005, vol: 28, page: 576, stat: Journal Article,

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia
Karbasian-Esfahani, Merat; Wiernik, Peter H; Novik, Yelena; Paietta, Elisabeth; Dutcher, Janice P
2004 Sep 15;101(6):1414-1419, Cancer
— id: 96878, year: 2004, vol: 101, page: 1414, stat: Journal Article,

Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy
Forman, Robin B; Benkel, Seth A; Novik, Yelena; Tsai, Han-Mou
2003 ;109(3):150-152, Acta haematologica
— id: 38008, year: 2003, vol: 109, page: 150, stat: Journal Article,

20th-century advances in drug therapy in oncology--Part I
Dutcher JP; Novik Y; O'Boyle K; Marcoullis G; Secco C; Wiernik PH
2000 Sep;40(9):1007-1024, Journal of clinical pharmacology
— id: 38010, year: 2000, vol: 40, page: 1007, stat: Journal Article,

20th-century advances in drug therapy in oncology--Part. II
Dutcher JP; Novik Y; O'Boyle K; Marcoullis G; Secco C; Wiernik PH
2000 Oct;40(10):1079-1092, Journal of clinical pharmacology
— id: 38009, year: 2000, vol: 40, page: 1079, stat: Journal Article,

Successful treatment of a patient on adrenal steroid replacement therapy with high-dose bolus interleukin-2 for metastatic renal cell carcinoma
Deshpande H; Dutcher JP; Novik Y; Oleksowicz L
1999 Jan-Feb;5(1):52-53, Cancer journal from Scientific American
— id: 38013, year: 1999, vol: 5, page: 52, stat: Journal Article,

Therapeutic efficacy of theophylline in chronic lymphocytic leukemia
Makower D; Malik U; Novik Y; Wiernik PH
1999 Apr;16(1):69-71, Medical oncology
— id: 38012, year: 1999, vol: 16, page: 69, stat: Journal Article,

Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
Novik Y; Ryan LM; Haller DG; Asbury R; Dutcher JP; Schutt A
1999 Dec;16(4):261-266, Medical oncology
— id: 38011, year: 1999, vol: 16, page: 261, stat: Journal Article,

Familial erythroleukemia: a distinct clinical and genetic type of familial leukemias
Novik Y; Marino P; Makower DF; Wiernik PH
1998 Jul;30(3-4):395-401, Leukemia & lymphoma
— id: 38014, year: 1998, vol: 30, page: 395, stat: Journal Article,

Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia
Novik Y; Oleksowicz L; Wiernik PH
1997 Mar;14(1):43-46, Medical oncology
— id: 38015, year: 1997, vol: 14, page: 43, stat: Journal Article,